These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 19330177

  • 1. The importance of 18F-FDG PET/CT, CT and X-rays in detecting primary stage III A lung cancer and the incidence of extra thoracic metastases.
    Sharma R, Tripathi M, D'Souza M, Jaimini A, Saw SK, Singh D, Mishra A, Mondal A.
    Hell J Nucl Med; 2009; 12(1):22-5. PubMed ID: 19330177
    [Abstract] [Full Text] [Related]

  • 2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 3. 18F-FDG PET/CT for staging of penile cancer.
    Scher B, Seitz M, Reiser M, Hungerhuber E, Hahn K, Tiling R, Herzog P, Reiser M, Schneede P, Dresel S.
    J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
    [Abstract] [Full Text] [Related]

  • 4. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [Abstract] [Full Text] [Related]

  • 5. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    Heusner T, Gölitz P, Hamami M, Eberhardt W, Esser S, Forsting M, Bockisch A, Antoch G.
    Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
    [Abstract] [Full Text] [Related]

  • 6. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [Abstract] [Full Text] [Related]

  • 7. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF.
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [Abstract] [Full Text] [Related]

  • 8. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G, Altini C, Notaristefano A, Merenda N, Rubini D, Ianora AA, Asabella AN.
    Rev Esp Med Nucl Imagen Mol; 2014 Jul; 33(1):22-7. PubMed ID: 23948509
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ.
    J Clin Oncol; 2009 Oct 01; 27(28):4774-80. PubMed ID: 19720925
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M.
    J Nucl Med; 2008 Feb 01; 49(2):195-200. PubMed ID: 18199607
    [Abstract] [Full Text] [Related]

  • 13. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.
    J Nucl Med; 2009 Apr 01; 50(4):506-12. PubMed ID: 19289438
    [Abstract] [Full Text] [Related]

  • 14. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X, Huang X, Yan W, Wu L, Dai K.
    Eur J Radiol; 2012 May 01; 81(5):1007-15. PubMed ID: 21354739
    [Abstract] [Full Text] [Related]

  • 15. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A, Xue J, Hu M, Zheng J, Wang X.
    Cancer Epidemiol; 2012 Oct 01; 36(5):470-5. PubMed ID: 22504050
    [Abstract] [Full Text] [Related]

  • 16. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G.
    Q J Nucl Med Mol Imaging; 2006 Mar 01; 50(1):15-22. PubMed ID: 16557200
    [Abstract] [Full Text] [Related]

  • 17. 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
    Koolen BB, Vrancken Peeters MJ, Aukema TS, Vogel WV, Oldenburg HS, van der Hage JA, Hoefnagel CA, Stokkel MP, Loo CE, Rodenhuis S, Rutgers EJ, Valdés Olmos RA.
    Breast Cancer Res Treat; 2012 Jan 01; 131(1):117-26. PubMed ID: 21935602
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
    Cai L, Gao S, Li DC, Li YS, Chen QS, Xing XL.
    Zhonghua Zhong Liu Za Zhi; 2009 Feb 01; 31(2):134-8. PubMed ID: 19538892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.